These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 17680782

  • 1. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis.
    Rayes N, Seehofer D, Kahl A, Kokott S, Pratschke J, Frei U, Neuhaus P.
    Transpl Int; 2007 Nov; 20(11):974-81. PubMed ID: 17680782
    [Abstract] [Full Text] [Related]

  • 2. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ, Malaise J, Moreno A, Crespo M, Fernández-Cruz L, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [Abstract] [Full Text] [Related]

  • 3. Cytomegalovirus infection in simultaneous pancreas-kidney transplantation.
    Malaise J, Ricart MJ, Moreno A, Crespo M, Fernández-Cruz L, Van Ophem D, Squifflet JP, EUROSPK Study Group.
    Transplant Proc; 2005 May; 37(6):2848-50. PubMed ID: 16182830
    [Abstract] [Full Text] [Related]

  • 4. Preemptive therapy is not adequate for prevention of cytomegalovirus disease in pancreas-kidney transplant recipients.
    López-Medrano F, Rueda B, Lizasoain M, Juan RS, Folgueira D, Andrés A, Morales JM, Jiménez C, Meneu JC, Aguado JM.
    Transpl Infect Dis; 2009 Oct; 11(5):400-4. PubMed ID: 19570139
    [Abstract] [Full Text] [Related]

  • 5. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F, Alberú J, Soto-Ramírez LE, González-Aguirre H, Muñoz Trejo T, Mancilla E, Díliz H, Correa-Rotter R, Sierra-Madero J.
    Rev Invest Clin; 2002 Oct; 54(3):198-203. PubMed ID: 12183888
    [Abstract] [Full Text] [Related]

  • 6. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.
    Murray BM, Subramaniam S.
    Transpl Infect Dis; 2004 Mar; 6(1):3-9. PubMed ID: 15225220
    [Abstract] [Full Text] [Related]

  • 7. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
    Fallatah SM, Marquez MA, Bazerbachi F, Schiff JR, Cattral MS, McGilvray ID, Norgate A, Selzner M, Rotstein C, Husain S.
    Clin Transplant; 2013 Mar; 27(4):503-9. PubMed ID: 23731387
    [Abstract] [Full Text] [Related]

  • 8. [The significance of risk-adapted antiviral prophylaxis and modern virus diagnosis for organ survival after kidney transplantation].
    Fricke L, Steinhoff J, Hartwig-Weber I, Bein G.
    Dtsch Med Wochenschr; 1997 May 02; 122(18):565-71. PubMed ID: 9190308
    [Abstract] [Full Text] [Related]

  • 9. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.
    Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC, Spivey JR, Paya CV.
    J Infect Dis; 2001 Dec 01; 184(11):1461-4. PubMed ID: 11709790
    [Abstract] [Full Text] [Related]

  • 10. Changing impact of cytomegalovirus in liver transplantation -- a single centre experience of more than 1000 transplantations without ganciclovir prophylaxis.
    Seehofer D, Rayes N, Neumann UP, Meisel H, Oettle H, Nüssler NC, Jonas S, Langrehr JM, Neuhaus P.
    Transpl Int; 2005 Aug 01; 18(8):941-8. PubMed ID: 16008744
    [Abstract] [Full Text] [Related]

  • 11. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
    Gotti E, Suter F, Baruzzo S, Perani V, Moioli F, Remuzzi G.
    Clin Transplant; 1996 Dec 01; 10(6 Pt 1):550-5. PubMed ID: 8996777
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N, Holman MJ, Yang HC.
    Clin Transplant; 1997 Dec 01; 11(6):633-9. PubMed ID: 9408699
    [Abstract] [Full Text] [Related]

  • 13. Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients.
    Israni A, Krok K, Cohen D, Blumberg E, Bloom RD.
    Transplant Proc; 2004 Dec 01; 36(10):3019-24. PubMed ID: 15686685
    [Abstract] [Full Text] [Related]

  • 14. Cytomegalovirus infection in renal transplant recipients.
    Carstens J, Andersen HK, Spencer E, Madsen M.
    Transpl Infect Dis; 2006 Dec 01; 8(4):203-12. PubMed ID: 17116133
    [Abstract] [Full Text] [Related]

  • 15. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
    Reischig T, Jindra P, Svecová M, Kormunda S, Opatrný K, Treska V.
    J Clin Virol; 2006 Jun 01; 36(2):146-51. PubMed ID: 16531113
    [Abstract] [Full Text] [Related]

  • 16. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J, Morales-Buenrostro LE, Correa-Rotter R, Muñoz-Trejo T, Zúñiga-Varga J, Cuéllar-González JV, Mayorga-Madrigal H, Vanegas-Carrero R, Aranda F, Rodríguez-Romo R, Herrera-Garcia C, González-Michaca L, Sierra-Madero JG.
    Rev Invest Clin; 2008 Jun 01; 60(5):365-74. PubMed ID: 19227433
    [Abstract] [Full Text] [Related]

  • 17. Ganciclovir prophylaxis to prevent CMV disease in kidney recipients undergoing anti-lymphocyte globulin treatment for acute rejection.
    Dickenmann MJ, Kabulbayev K, Steiger J, Cathomas G, Reusser P, Tamm M.
    Clin Microbiol Infect; 2004 Apr 01; 10(4):337-9. PubMed ID: 15059125
    [Abstract] [Full Text] [Related]

  • 18. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P, Dvornik S, Husnjak SC, Aralica M, Orlić L, Zivcić-Cosić S, Sladoje-Martinović B, Fućak M.
    Acta Med Croatica; 2003 Apr 01; 57(1):49-52. PubMed ID: 12876863
    [Abstract] [Full Text] [Related]

  • 19. Cytomegalovirus infection in kidney transplant recipients: Evolution of approach through three eras.
    Boucher A, Lord H, Collette S, Morin M, Dandavino R.
    Transplant Proc; 2006 Dec 01; 38(10):3506-8. PubMed ID: 17175316
    [Abstract] [Full Text] [Related]

  • 20. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
    Seehofer D, Rayes N, Tullius SG, Schmidt CA, Neumann UP, Radke C, Settmacher U, Müller AR, Steinmüller T, Neuhaus P.
    Liver Transpl; 2002 Dec 01; 8(12):1138-46. PubMed ID: 12474153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.